As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Moderate to Severe Overactive Bladder Study

Clinical Trial Title: 
Study for the treatment of moderate to severe overactive bladder with urgency and incontinence
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Barbara Soltes, MD
Clinical Trial Protocol Description: 

This is a study for men and women with moderate to severe urinary urge incontinence with symptoms for greater than six months.

Treatment is for 12 weeks with a medication that is currently approved for use in this indication and is comparing efficacy between two doses of the medication and placebo.

There are three clinic visits and two telephone contacts.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 years old or greater.
  • Have symptoms of overactive bladder for more than six months.
  • Have a urinary frequency (using restroom) eight or more times per 24 hours.
  • Have occasions of incontinence (leaking).

This is a partial list of eligibility requirements. 

Clinical Trial Area: 
Kidney and Urinary System Disorders
Contact Phone: 
(312) 563-2611
Contact Name: 
Carol Miller